PriceTargets.com logo

Medicine Man Technologies - SHWZ Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $2.50
  • Forecasted Upside: 45,354.55%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.01 As of 04/17/2025 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for SHWZ by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medicine Man Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SHWZ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SHWZ

Analyst Price Target is $2.50
▲ +45,354.55% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Medicine Man Technologies in the last 3 months. The average price target is $2.50, with a high forecast of $2.50 and a low forecast of $2.50. The average price target represents a 45,354.55% upside from the last price of $0.01.

This chart shows the closing price for SHWZ for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Medicine Man Technologies. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/23/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/20/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/18/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/19/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/18/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/14/2024BenchmarkReiterated RatingBuy ➝ Buy$2.50 ➝ $2.50
5/16/2024BenchmarkReiterated RatingBuy ➝ Buy$2.50
3/28/2024BenchmarkLower TargetBuy ➝ Buy$3.00 ➝ $2.50
3/30/2023BenchmarkReiterated RatingBuy$3.00
10/28/2022BTIG ResearchInitiated CoverageBuy
12/14/2021BenchmarkInitiated CoverageBuy$4.00
12/27/2020Noble FinancialReiterated RatingBuy$4.00
(Data available from 4/19/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/21/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/21/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/20/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/20/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/19/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/18/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Medicine Man Technologies

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.
Read More

Today's Range

Now: $0.01
Low: $0.01
High: $0.01

50 Day Range

MA: $0.01
Low: $0.00
High: $0.05

52 Week Range

Now: $0.01
Low: $0.00
High: $0.84

Volume

N/A

Average Volume

8,716 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Medicine Man Technologies?

The following equities research analysts have issued research reports on Medicine Man Technologies in the last twelve months: Benchmark Co..
View the latest analyst ratings for SHWZ.

What is the current price target for Medicine Man Technologies?

0 Wall Street analysts have set twelve-month price targets for Medicine Man Technologies in the last year. Their average twelve-month price target is $2.50, suggesting a possible upside of 45,354.5%. Benchmark Co. has the highest price target set, predicting SHWZ will reach $2.50 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $2.50 for Medicine Man Technologies in the next year.
View the latest price targets for SHWZ.

What is the current consensus analyst rating for Medicine Man Technologies?

Medicine Man Technologies currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SHWZ will outperform the market and that investors should add to their positions of Medicine Man Technologies.
View the latest ratings for SHWZ.

What other companies compete with Medicine Man Technologies?

Other companies that are similar to Medicine Man Technologies include (CAME), (CLEA), Access Worldwide Communications, AcuityAds and Adaptive Medias. Learn More about companies similar to Medicine Man Technologies.

How do I contact Medicine Man Technologies' investor relations team?

Medicine Man Technologies' physical mailing address is 4880 Havana Street, Suite 201, Denver, CO 80239, United States. The company's listed phone number is (303) 371-0387. The official website for Medicine Man Technologies is www.schwazze.com. Learn More about contacing Medicine Man Technologies investor relations.